"I should be one of the enthusiastic ones, but in reality, I'm one of the skeptics, or cautious at least," says Riccardo De Giorgi, psychiatrist and clinical researcher who studies mental health and GLP-1s at the University of Oxford
GLP-1 diabetes and weight-loss drug side effects: Ozempic face and more
Talking exclusively to ET about the possible price range for Ozempic, Vikrant Shrotriya, India head of Novo Nordisk, had recently said: "We are very watchful of the situation
Despite extensive research, the full implications of weight loss associated with SGLT2 inhibition are largely unknown
Contact Klinic's representatives to discuss financial aspects and insurance eligibility for weight loss management
The current listing is available through Strand Bio's standard checkout